Concepedia

Soichiro Nishijima

SN

Statistics

Publications

5

Citations

162

H-Index

5

Active since

2005

Affiliations

Daiichi-Sankyo (Japan)(Current)

Tokyo Women's Medical University

Kyoto University

First Hospital of Jilin University

Hiroshima University Hospital

Soichiro Nishijima is an author at Daiichi-Sankyo (Japan) specializing in oncology, neuro-oncology, and cancer pharmacology.

ORCID

Publications per year

2005–2024

5

Publications

5

The first-in-human phase I study of a brain-penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomas

Atsushi Natsume, Yoshiki Arakawa, Yoshitaka Narita et al. · Neuro-Oncology · 2022 · 84 citations · Full text

, , +8

Phase I study of a brain penetrant mutant IDH1 inhibitor DS-1001b in patients with recurrent or progressive <i>IDH1</i> mutant gliomas.

Atsushi Natsume, Toshihiko Wakabayashi, Yasuji Miyakita et al. · Journal of Clinical Oncology · 2019 · 24 citations

, , +15

Trastuzumab deruxtecan versus treatment of physician’s choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study

Toshinari Yamashita, Joohyuk Sohn, Eriko Tokunaga et al. · Breast Cancer · 2024 · 22 citations · Full text

, , +17

Trastuzumab deruxtecan versus trastuzumab emtansine in Asian patients with HER2‐positive metastatic breast cancer

Hiroji Iwata, Binghe Xu, Sung‐Bae Kim et al. · Cancer Science · 2024 · 20 citations · Full text

, , +16

Evaluation of Genotoxicity of 3-Amino-, 3-Acetylamino- and 3-Nitrobenzanthrone Using the Ames/Salmonella Assay and the Comet Assay

Tetsushi Watanabe, T. Tomiyama, Soichiro Nishijima et al. · JOURNAL OF HEALTH SCIENCE · 2005 · 12 citations · Full text

, , +15

1–5 of 5